Showing results (1-10 of 253) with videos related to
Sort By:
Pageof 26
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 1, 1997
Idiopathic inflammatory myopathies: optimum immunosuppressive treatmentP J Zilko, F L Mastaglia, B A PhillipsMuscle & Nerve|June 8, 2000
Prevalence of sporadic inclusion body myositis in Western AustraliaB A Phillips, P J Zilko, F L MastagliaJournal of Neurology, Neurosurgery, and Psychiatry|July 17, 1998
Immunoglobulin therapy in inflammatory myopathiesF L Mastaglia, B A Phillips, P J ZilkoJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 5, 2002
Inflammatory myopathies: how to treat the difficult casesF L Mastaglia, P J ZilkoMuscle & Nerve|December 18, 2001
Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging studyB A Phillips, L A Cala, G W Thickbroom, et al.Australian and New Zealand Journal of Medicine|February 1, 1984
Guillain-Barré syndrome and pemphigus foliaceus associated with D-penicillamine therapyW Knezevic, F L Mastaglia, J Quintner, et al.Current Opinion in Neurology|November 10, 2000
Exercise therapy in patients with myopathyB A Phillips, F L MastagliaClinical and Experimental Immunology|October 1, 1994
HLA associations with inclusion body myositisM J Garlepp, B Laing, P J Zilko, et al.Archives of Physical Medicine and Rehabilitation|May 12, 2000
Muscle force measured using "break" testing with a hand-held myometer in normal subjects aged 20 to 69 yearsB A Phillips, S K Lo, F L MastagliaPageof 26